Publication: 2050

Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 19 (24) 6957-6966
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
3
Parents:
598  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, U10 CA032291, CA33601, CA77597, CA04457, CA11789, U10 CA077658, CA77406, CA47577, CA32291, U10 CA086726, U10 CA045564, CA41287, U10 CA045808, CA03927, U10 CA031946, CA77651, U10 CA033601, U10 CA045389, CA59518, CA26806, CA45389, U10 CA077597, CA45808, U10 CA059518, U10 CA035421, U10 CA114558, CA12046, U10 CA045418, CA35421, CA86726, U10 CA077440, CA16450, CA77440, U10 CA041287, CA45564, U10 CA047559, U10 CA077651, CA04326, CA08025, CA74811, CA21060, P30 CA016058, CA47559, CA114558-02, CA47642, CA45418, U10 CA074811, CA77658, CA37135, CA77298, U10 CA047642, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
                   
Networks:
 
Study
CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article